MIRA Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2022-08-01: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2022-07-22; Total offering amount $3,000,000.
- 2022-08-01: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-11-09; Total offering amount $6,511,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2022-08-01 | Rule 506(b) | Equity | 2022-07-22 | $3,000,000 | $625,000 | $2,375,000 | 8 |
|---|
| 2022-08-01 | Rule 506(b) | Equity | 2021-11-09 | $6,511,000 | $6,511,000 | $0 | 76 |
|---|